Category Archives for "Patient Safety"

Mammography Quality Concerns Prompt FDA Intervention at North Jersey Imaging Facility

By Angela Leone

On May 21st, the US Food and Drug Administration (FDA) issued a “Safety Communication” regarding Advanced Women’s Imaging (AWI), located in Guttenberg, NJ. Patients who had mammograms performed at AWI anytime on or after March 11, 2020 are being made aware of possible problems with the quality of their mammograms. Potential Medical Malpractice from Faulty […]

Continue reading

Zantac Recall: What If My Doctor is Still Prescribing Zantac?

By Justin Groen

Let’s start with the obvious: no doctor wakes up in the morning and thinks to themselves, “I would like to prescribe a known carcinogen to one of my patients today.” BUT – if your doctor is currently prescribing you Zantac or ranitidine to treat your acid reflux, GERD, or other heartburn related ailments, then that […]

Continue reading

What is Zantac and What is it Used to Treat?

By Ashley B. DiLiberto

Ever since the end of 2019, Zantac has been in the news pretty frequently. First for warnings, then voluntary recalls, than an offical Zantac recall by the FDA, and now because of a growing multi-district litigation in Florida on behalf of hundreds of victims who took the drug and were later diagnosed with cancer. But […]

Continue reading

Zantac ordered off the shelves by FDA due to Cancer causing NDMA

By Joe Messa

The U.S. Food and Drug Administration (FDA) issued a press release today requesting that manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This comes months after the FDA announced its initial warning regarding ranitidine medications (brand name ZANTAC) and the possible presence of a contaminant known as N-Nitrosodimethylamine (NDMA). NDMA […]

Continue reading

New Jersey Politicians Attempt to Control where New Jersey Patients can Receive Medical Treatment with Bipartisan ‘Patient Protection Act’

By Joe Messa

A bill currently moving through the New Jersey legislature aims to seriously limit physicians’ choices when it comes to the treatment of their patients. The bill (S-3816/A-5369), called the ‘Patient Protection Act,’ imposes lengthy, time-consuming processes on physicians who want to transfer or refer patients to out-of-state medical providers. The bill claims to protect patients […]

Continue reading

FDA Connects Edwards Lifesciences’ Recalled Heart Device to Three Deaths

By Joe Messa

The United States Food and Drug Administration announced on Monday that they have classified a voluntary recall of Edwards Lifesciences Corp heart devices as Class I after three deaths were associated with the defective devices. Class I is the most urgent recall issued by the FDA, reserved for defective devices that can cause serious injury […]

Continue reading

RECALL: Infant Ibuprofen sold at Walmart, CVS, and Family Dollar

By Joe Messa

Tris Pharma, Inc., a New Jersey based pharmaceutical manufacturer, has issued a voluntary recall of infant ibuprofen that may contain higher concentrations than noted on the bottle, leading to potential risks in infants. The impacted lots of medication were sold to a distributor that supplies retailers, including CVS, Walmart, and Family Dollar. Retailers and wholesalers […]

Continue reading

Eleven children have died as the result of a viral outbreak in a NJ care facility

By Joe Messa

An eleventh child died late last week as the result of an adenovirus outbreak at the Wanaque Center for Nursing and Rehabilitation in Haskell, New Jersey. The Wanaque Center is a professional nursing home, rehabilitation center, and pediatrics center offering short and long term care. Patients in the pediatrics center are severely disabled children, often […]

Continue reading

URGENT FDA WARNING: MAMMOGRAPHY PROBLEMS AT A MANAHAWKIN, NJ IMAGING CENTER

By Joe Messa

On September 24th, the US Food and Drug Administration (FDA) issued a “Safety Communication” regarding Aims Diagnostic Imaging, located in Manahawkin, NJ. Patients who had mammograms at Aims Diagnostic anytime on or after June 15, 2017 are being made aware of possible problems with the quality of their mammograms. According to the FDA’s announcment, “This […]

Continue reading